Aisling Capital is a venture capital and private equity firm investing in healthcare and biotechnology companies that is headquartered in New York City, New York and was founded in 2000.
Investments
The firms invests primarily in companies commercializing healthcare products, services, and technologies. Aisling Capital has raised about $1.8 billion in committed capital across 4 investment funds and has made 106 investments. Notable investments made by the firm include: Dermira, BridgeBio, Atreca, TransEnterix, ViewRay, T2 Biosystems, Arcus Biosciences, Aimmune Therapeutics, Eidos Therapeutics, and Avrobio.
Timeline
Invested in
Patents
Funding Rounds Participated In
Further Resources
Title
Author
Link
Type
Date
News
Title
Author
Date
Publisher
Description
FinSMEs
September 24, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.